About EndoGastric Solutions
EndoGastric Solutions is a company based in San Mateo (United States) founded in 2002. EndoGastric Solutions has raised $355.2 million across 18 funding rounds from investors including Canaan, Accelmed and Canepa Healthcare. The company has 80 employees as of December 31, 2022. EndoGastric Solutions offers products and services including EsophyX® Device, TIF 2.0®, and cTIF™. EndoGastric Solutions operates in a competitive market with competitors including EndoChoice, CoapTech, SafeStitch, Endo Tools Therapeutics and EndoStim, among others.
- Headquarter San Mateo, United States
- Employees 80 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Endogastric Solutions, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$355.2 M (USD)
in 18 rounds
-
Latest Funding Round
$27 M (USD), Series J
Dec 03, 2021
-
Investors
Canaan
& 11 more
-
Employee Count
80
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of EndoGastric Solutions
EndoGastric Solutions offers a comprehensive portfolio of products and services, including EsophyX® Device, TIF 2.0®, and cTIF™.
Treats GERD through transoral incisionless fundoplication procedure.
Restores stomach anatomy to prevent acid reflux in patients.
Offers standardized fundoplication for digestive disease management.
People of EndoGastric Solutions
Unlock access to complete
Funding Insights of EndoGastric Solutions
EndoGastric Solutions has successfully raised a total of $355.2M across 18 strategic funding rounds. The most recent funding activity was a Series J round of $27 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in EndoGastric Solutions
EndoGastric Solutions has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Canaan, Accelmed and Canepa Healthcare.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Canaan is recognized as an early-stage venture capital firm.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for EndoGastric Solutions
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by EndoGastric Solutions
Investment portfolio details for EndoGastric Solutions
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - EndoGastric Solutions
Detailed financials for EndoGastric Solutions
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Endogastric Solutions Comparisons
Peer comparison for EndoGastric Solutions
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of EndoGastric Solutions
EndoGastric Solutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EndoChoice, CoapTech, SafeStitch, Endo Tools Therapeutics and EndoStim, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Devices, systems, and services are provided for GI specialists.
|
|
| Locked | Locked | Locked |
Minimally invasive gastrostomy feeding tube placement method is developed.
|
|
| Locked | Locked | Locked |
Medical devices for gastrointestinal and bariatric surgery are developed.
|
|
| Locked | Locked | Locked |
Endoscopic catheters for precision in gastroenterology are developed.
|
|
| Locked | Locked | Locked |
Implant to treat GERD
|
Detailed competitors of EndoGastric Solutions
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Endogastric Solutions
Complete news archive for EndoGastric Solutions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EndoGastric Solutions
EndoGastric Solutions was founded in 2002 and raised its 1st funding round 1 year after it was founded.
EndoGastric Solutions is headquartered in San Mateo, United States. It is registered at San Mateo, California, United States.
Skip Baldino is the current CEO of EndoGastric Solutions.
EndoGastric Solutions is a funded company, having raised a total of $355.2M across 18 funding rounds to date.
As of Dec 31, 2022, the latest employee count at EndoGastric Solutions is 80.
EndoGastric Solutions was founded in 2002 in San Mateo, United States, as a medical technology firm focused on the gastrointestinal sector. Devices such as EsophyX and Stomaphyx are designed and manufactured for endoluminal transoral applications, including tissue approximation, placation, and ligation. These tools address conditions like gastroesophageal reflux disease and other upper GI disorders through minimally invasive techniques. Operations center on innovation in natural orifice surgery methods.
EndoGastric Solutions's top competitors include CoapTech, Endo Tools Therapeutics and EndoChoice.
EndoGastric Solutions offers EsophyX® Device, TIF 2.0®, and cTIF™.
EndoGastric Solutions has 12 investors. Key investors include Canaan, Accelmed, Canepa Healthcare, Chicago Growth Partners, and Radius Ventures.